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Department of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WisconsinABSTRACT Constraint-based methods provide powerful computational techniques to allow understanding and prediction of
cellular behavior. These methods rely on physiochemical constraints to eliminate infeasible behaviors from the space of
available behaviors. One such constraint is thermodynamic feasibility, the requirement that intracellular flux distributions
obey the laws of thermodynamics. The past decade has seen several constraint-based methods that interpret this constraint
in different ways, including those that are limited to small networks, rely on predefined reaction directions, and/or neglect the
relationship between reaction free energies and metabolite concentrations. In this work, we utilize one such approach,
thermodynamics-based metabolic flux analysis (TMFA), to make genome-scale, quantitative predictions about metabolite con-
centrations and reaction free energies in the absence of prior knowledge of reaction directions, while accounting for uncertainties
in thermodynamic estimates. We applied TMFA to a genome-scale network reconstruction of Escherichia coli and examined the
effect of thermodynamic constraints on the flux space. We also assessed the predictive performance of TMFA against gene
essentiality and quantitative metabolomics data, under both aerobic and anaerobic, and optimal and suboptimal growth condi-
tions. Based on these results, we propose that TMFA is a useful tool for validating phenotypes and generating hypotheses, and
that additional types of data and constraints can improve predictions of metabolite concentrations.INTRODUCTIONGenome-scale network reconstructions provide concise
mathematical representations of an organism’s biochemical
capabilities, and serve as a platform for constraint-based
techniques that can be used for understanding and predicting
cellular behavior (1,2). The predictive accuracy of
constraint-based methods depends on the degree to which
constraints eliminate physiochemically and biologically
infeasible behaviors.
Flux-balance analysis (FBA) (3) is commonly employed
to predict the state of the network by identifying a steady-
state flux distribution maximizing cellular growth, while
also satisfying mass-balance and enzyme capacity con-
straints. Reaction directionality is typically assigned based
on enzyme assays or biological considerations (e.g., no
free ATP synthesis), with no consideration given to thermo-
dynamic feasibility. The second law of thermodynamics
states that a negative Gibbs energy of reaction (Dr G) is
needed to drive a forward reaction flux, v, leading to the
thermodynamic feasibility constraint v $ Dr G > 0 for
nonzero v.
The first attempt to enforce thermodynamic feasibility on
FBAwas energy balance analysis (EBA) (4,5), which incor-
porated nonlinear constraints on chemical potentials into
FBA to eliminate closed cycles. Closed cycles are sets of
reactions for which the overall thermodynamic driving force
is zero, and through which no net flux can occur (e.g., A/
B / C / A). These closed cycles have been variously
referred to as Type III pathways (6), internal flux cyclesSubmitted October 5, 2012, and accepted for publication June 5, 2013.
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0006-3495/13/07/0512/11 $2.00(7), and loops (8). Because its constraints are nonlinear,
EBA is restricted to small models, though a scalable algo-
rithm has recently been proposed (9). The same scientists
also developed a method to compute and eliminate closed
cycles in flux-balance models (10,11) based solely on
stoichiometry, although the technique remains computa-
tionally demanding for genome-scale networks. Recently,
a scalable, mixed-integer approach to eliminating closed
cycles has also been developed (8).
Due to the limited availability of free energy data for
reactions and metabolites (12,13), many of the above
approaches do not directly account for the relationships
among Dr G, metabolite concentrations, and free energies
of formation (Df G). Fortunately, group contribution
methods (GCMs) (14–16) have been developed to estimate
free energies of metabolites and reactions for which data are
unavailable. A recent model of Escherichia coli used one
such GCM to assign reaction directionalities based on
thermodynamic feasibility (16,17). In other approaches,
experimentally measured thermodynamic data have been
combined with heuristics and/or group contribution data to
define feasible reaction directions in E. coli (18,19). How-
ever, these approaches (17–19) neglect thermodynamic
interactions between reactions in the network that arise
due to shared metabolites. As a result, the directionality
of a reaction is assigned independently of other reaction
directions in the network. For example, two reactions
may be feasible in both the forward and reverse directions,
but due to a shared metabolite, the pair of reactions must
proceed in the same direction. These approaches fail to
capture this type of thermodynamic coupling between
reactions.http://dx.doi.org/10.1016/j.bpj.2013.06.011
Quantitative Assessment of TMFA 513GCMs have also been used in approaches that capture
thermodynamic interactions by including metabolite con-
centrations as variables. EBA has been extended to predict
intracellular metabolite concentrations in a small network
(20), and two mixed-integer approaches have also been
developed, in which thermodynamic constraints are
imposed on top of predefined reaction directions. NET
analysis (21) integrates quantitative metabolomics data
with thermodynamic constraints to predict feasible free
energy ranges for all reactions in the network. Another
method, thermodynamics-based metabolic flux analysis
(TMFA) (7), extends FBAwith thermodynamic constraints,
enabling the quantitative prediction of feasible ranges of
metabolite concentrations and reaction free energies,
without relying on metabolomic data. However, both of
these methods have, to date, relied on prior knowledge of
the reversibility or directionality of reactions (7,21–23),
thereby restricting their predictive capabilities.
In this work, we examine the extent to which thermody-
namics-based flux-balance methods can make genome-
scale, quantitative predictions, in the absence of outside
information on flux directions, considering both the presence
and absence of uncertainty in thermodynamic estimates. To
this end, we applied TMFA to the iJR904 model of E. coli
(24). This model was used because group contribution esti-
mates are available for a higher fraction of the metabolites
in the iJR904 model than in newer models (16). We assessed
the predictive performance of TMFA against a number of
large-scale datasets (22,25–27), encompassing metabolite
concentrations and gene deletion phenotypes, under both
aerobic and anaerobic, and optimal and suboptimal growth
conditions. Through this analysis, we highlight the impor-
tance of quantitative concentration measurements and
thermodynamic coupling in achieving physiologically real-
istic predictions of growth rates and flux distributions. We
were also able to generate hypotheses regarding metabolite
concentrations and thermodynamic bottlenecks, and we
discuss additional types of data and constraints that can
improve predictions of metabolite concentrations.MATERIALS AND METHODS
Overview and relationship to previous
implementations
Given a stoichiometric matrix S and set of reactions J, flux-balance analysis
(FBA) seeks a steady-state flux distribution (v) maximizing the flux through
the biomass reaction (vBM), while also satisfying mass-balance and enzyme
capacity constraints for individual reactions, j:
max vBM; (1)
s:t: S$v ¼ 0; (2)0%vj%vmax cj˛Jirrev; (3)vmin%vj%vmax cj;Jirrev: (4)Because the network is at steady state, net production of all metabolites is
zero. Each reaction is further constrained to have flux within an appropriate
range as given by enzyme capacities, with some reactions assumed to be
irreversible (j ˛ Jirrev). The limits through most reactions are set to vmax ¼
1000 mmol/gDW/h and vmin ¼ 1000 mmol/gDW/h, except for measured
fluxes (e.g., carbon uptake rates).
Previous implementations of TMFA (7,23) have imposed thermody-
namic constraints on top of FBA, thereby allowing these constraints to
further restrict reaction directions; however, a reaction deemed irreversible
in FBA cannot become reversible even if indicated by the thermodynamic
constraints. In contrast, our implementation makes no assumptions about
reaction (ir)reversibility, allowing thermodynamic constraints to decide
the directions of all reactions. We replaced Eqs. 3 and 4 with
vmin%vj%vmax cj˛J (5)
and rely on thermodynamic constraints alone to determine reaction
directions.Calculating free energies of reaction
Enforcing thermodynamic constraints requires knowledge of the standard
transformed Gibbs energy of reaction (Dr G
00) for the reactions in the
model. Due to a paucity of experimental data, group contribution methods
(14,15) are used to provide estimates and uncertainties of the standard trans-
formed Gibbs energy of formation (Df G
00) for metabolites and of reaction
(Dr G
00) for reactions.
GCMs assume that the Df G
00 of a metabolite i is a linear combination
of the formation energies of its constituent molecular substructures
(or groups), k,
Df G
00
i ¼
X
k
ni;kDgrG
00
k ; (6)
where Dgr Gk
00 is the estimated contribution of group k to the overall Df G
00,
and ni,k is the number of groups k in the molecular structure of compound i.
We used a software implementation of the GCM of Jankowski et al. (16),
Henry et al. (28), and Finley et al. (29) to obtain estimates and uncertainties
of Df G
00 and Dr G
00 for metabolites and reactions in the iJR904 network
(see the Supporting Methods and Table S1 and Table S2 in the Supporting
Material).
The GCM method returns estimates of Df G
00 for the predominant ionic
species at biochemical standard state: pH 7, zero ionic strength, and temper-
ature 298 K. Simulations were performed at conditions of 298 K and zero
ionic strength, at a pH of 7 (7.4) for intra- (extra)cellular metabolites, using
the ionic species represented in the iJR904 model stoichiometric matrix.
These differences in pH and major ionic species required adjusting the
GCM estimates of Df G
00 (see the Supporting Material).
Using our new estimates of Df G
00, we calculated Dr G
00from the stoichi-
ometry of each reaction,
DrG
00
j ¼
X
i
Si;jDf G
00
i ; (7)
where Si, j is the stoichiometric coefficient of metabolite i in reaction j. We
then calculated the transformed Gibbs energy of reaction (Dr G
0
) as a
function of metabolite concentration, xi,
DrG
0
j ¼ DrG
00
j þ RT
X
i
Si;j lnðxiÞ þ DtG00j ; (8)
where R is the gas constant, T is the temperature (298 K), and Dt G
00 reflects
the contribution to D G
0
from the transport of metabolites across therBiophysical Journal 105(2) 512–522
514 Hamilton et al.membrane. Following an established derivation (7), we calculated Dt G
00 as
a function of the electrochemical potential (DJ) and pH gradient (DpH)
across the membrane,
DtG
00
j ¼ cjFDJ 2:3 hjRTDpH; (9)
where F is Faraday’s constant, cj is the net charge transported from outside
to inside the cell, and hj is the number of protons transported across the
membrane (see Table S3 for details). Our constraints on intra- and extracel-
lular proton concentrations resulted in values of 130 mV for DJ, and 0.4
for DpH (7,30).
We performed simulations with and without uncertainties in the esti-
mates for Dgr G
00 of each group. In TMFA, we fixed values of Dgr G
00 to
their estimated values (Dgr Gest
00) as given by the group contribution
method,
DgrG
00
k ¼ DgrG
00
k;est: (10)
Whereas in relaxed TMFA (RTMFA), we allowed Dgr G
00 of each group to
vary within its 95% confidence interval, as determined by the standard error
(SE) reported by the GCM software (i.e., SEDgrG00k;est
):
DgrG
00
k;est2SEDgrG00k;est%DgrG
00
k%DgrG
00
k;estþ2SEDgrG00k;est : (11)
See the Supporting Methods in the Supporting Material for additional
details.Enforcing thermodynamic consistency
Thermodynamic consistency requires that reaction fluxes are con-
sistent with predicted values of Dr G
0
(i.e., v $ Dr G < 0). We employed
a mixed-integer approach to enforce this requirement, in which a binary
variable d indicates if a reaction is operating in the forward (d ¼ 1)
or reverse (d ¼ 0) direction. We then added the following equations to
our model:
ð1 dÞvmin%v%dvmax; (12)
Mdþ ε%D G0%Mð1 dÞ  ε: (13)r
Here Eq. 13 is a big-M constraint (31) in whichM is an upper limit on Dr G
0
(300 kcal/mol) and ε is a small nonzero number (106). Equations 1, 2, 5–9,
and 12–13 were used in TMFA and equations 1, 2, 5–8, and 10–13 were
used in RTMFA.Flux and thermodynamic variability analysis
We performed flux and thermodynamic variability analysis under a
variety of conditions to identify thermodynamically feasible flux and
metabolite concentration ranges. In flux variability analysis (FVA) (32),
the flux v through each reaction is minimized and maximized subject to
the constraints of TMFA. In thermodynamic variability analysis (TVA)
(7), the concentration of each metabolite (or Dr G
0
of each reaction) is
minimized and maximized subject to the constraints of TMFA. Additional
details can be found in the Supporting Methods in the Supporting
Material.
Using our FVA results, we defined sets of reactions that can operate only
in the forward (Jfor) or reverse (Jrev) directions, or are blocked (Jbl) entirely.
By imposing the following constraints on our model, wewere able to reduce
simulation times by over an order of magnitude:
dj ¼ 1cj˛Jfor; (14)Biophysical Journal 105(2) 512–522vjR0cj˛Jfor; (15)dj ¼ 0cj˛Jrev; (16)vj%0cj˛Jrev; (17)vj ¼ 0cj˛Jbl: (18)For some reactions, flux maximization using RTMFAwas computationally
intensive, so all FVA simulations were performed with a time limit of 5 min.
As a result, there is a possibility that true flux ranges are larger than reported
(see the Results).Differences in phenotype: CONGA
We used an algorithm we previously developed, CONGA (33), to identify
single, double, and triple gene deletions predicted to be lethal in FBA but
not TMFA (or RTMFA). CONGA employs a bilevel optimization problem
to identify gene deletion strategies maximizing the difference in
maximum biomass flux between two different models, FBA and TMFA
(or RTMFA). Because the maximum possible difference in biomass flux
occurs when one model has zero biomass flux, CONGA identifies gene
deletions that are lethal in only one model. Additional details can be
found in the Supporting Methods in the Supporting Material and the
original work (33).Synthetic lethals and phenotype correction
Once we identified gene deletions lethal only in the FBA model, we
employed the synthetic lethals (SL) Finder (34) to identify the reaction(s)
responsible for the difference in predicted phenotype. SL Finder employs
a bilevel optimization problem to identify reaction deletion strategies that
minimize the maximum biomass flux through a network. Because the
lowest maximum biomass is zero, SL Finder finds lethal reaction
deletions. Additional details can be found in the Supporting Methods in
the Supporting Material and the original work (34).
For some gene deletions predicted to be lethal in FBA, the TMFA pre-
diction disagreed with experimental observation. This suggested that the
SL reaction did not operate in vivo in the direction predicted by FBA. In
these instances, we developed a constraint on metabolite concentrations
that prevented the SL reaction from operating in the TMFA-predicted
direction, thereby correcting the phenotype. We refer to such constraints
as phenotype-correction constraints. Additional details can be found in
the Supporting Methods in the Supporting Material.Simulation conditions
All simulations were performed using CPLEX 12 (IBM, Armonk, NY)
accessed via the General Algebraic Modeling System, Ver. 23.3.3 (GAMS;
GAMSDevelopment Corporation,Washington, DC). Simulations were per-
formed on a Red Hat Enterprise Linux server with 2.66 GHz Intel Xeon pro-
cessors and 8 GB of RAM. The TMFA formulation solves in a few seconds,
whereas the RTMFA formulation takes ~1 h to prove global optimality.Sources of experimental data and experimental
methods
Details on the experimental datasets and methods used to validate our
TMFA predictions are given in Supporting Methods in the Supporting
Material.
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FIGURE 1 Examples of thermodynamically feasible but physiologically
implausible behavior. (A) RTMFA predicts ATP can be synthesized by
cycling small molecules across the membrane. One such cycle involves
asp. (B) Metabolite concentration ranges predicted by RTMFA for which
the cycle shown in panel A is thermodynamically feasible (columns 1
and 2), and experimentally measured metabolite concentrations (column
3). (Highlighted type) Constraining this concentration in the model renders
the cycle thermodynamically infeasible.
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Optimization of aerobic growth on glucose using
TMFA
We first used thermodynamics-based metabolic flux anal-
ysis (TMFA) to determine the maximum growth rate of
E. coli under glucose aerobic conditions, using the iJR904
genome-scale metabolic model (24). Building on previous
work (7), we constrained the concentration of intracellular
metabolites to a range of 0.001–20 mM. We constrained
the concentrations of extracellular nutrients to that of
0.4% glucose MOPS medium (35). The concentration of
intracellular Hþ was fixed to a pH of 7, and extracellular
Hþ to a pH of 7.4. The concentration of extracellular gases
(O2 and CO2) was based on experimental measurement (36),
with a requirement that the intracellular concentration be
less than the extracellular concentration. Under these con-
ditions, TMFA predicted a maximum growth rate of zero,
suggesting that growth was not possible due to the thermo-
dynamic infeasibility of one or more essential reactions. We
expanded the concentration range of seven metabolites to
enable thermodynamic feasibility of eight essential reac-
tions (see Supporting Results in the Supporting Material).
All simulations were performed with glucose as the limiting
substrate, with a maximum uptake rate of 10 mmol/gDW/h.
The full set of metabolite concentration and exchange flux
constraints can be found in Table S6.
We first performed simulations neglecting the uncertainty
in the standard Gibbs energy of formation of each group
(Dgr G
00) (Eq. 10). The maximum growth rate predicted
by TMFA exceeded that of FBA by only 2%, despite the
increased network flexibility made possible by the lack of
predefined reaction directions in TMFA.
We then introduced uncertainty in Dgr G
00 (Eq. 11) and
observed that the maximum growth rate exceeded that of
FBA by ~12%. This elevated growth rate highlights the
additional network flexibility made possible by the uncer-
tainty in free energy estimates arising from the GCM. In
particular, the growth rate difference was due to mecha-
nisms in the relaxed TMFA model (RTMFA) that enable
ATP to be synthesized at lower energetic cost than occurs
physiologically (and is reflected in FBA). For example,
RTMFA should predict ATP synthesis via ATP synthase,
using energy released from the transport of four protons
across the plasma membrane. Instead, the RTMFA model
identifies numerous cycles that synthesize ATP using energy
released from the transport of fewer numbers of protons, by
shuttling metabolites back and forth across the plasma mem-
brane (Fig. 1 A). One such metabolite is aspartate (asp),
which enables ATP to be synthesized using energy released
from the transport of only two protons across the plasma
membrane. However, this shuttling relies on the aspartate
ABC-type transporter pumping out aspartate, which re-
quires ADP to be present at a concentration higher thanATP (Fig. 1 B). By additionally constraining the concentra-
tion of ATP to its experimentally measured range (22), in
which ATP is present at a higher concentration than ADP,
we can force the RTMFA model to use ATP synthase to
synthesize ATP. When a constraint on ATP concentration
is added to the model, the predicted growth rate exceeds
FBA by only 3%. This constraint on ATP concentration
was used in all subsequent RTMFA simulations discussed
in this work.Flux variability analysis: thermodynamically
feasible reaction directions
We then used flux variability analysis (FVA) to determine
thermodynamically feasible directions for all reactions in
the network under glucose aerobic conditions (Fig. 2 A,
and see Table S7 and Table S8). We classified reactions as
fully bidirectional, or constrained in one of three ways:
blocked entirely; capable of operating in the forward direc-
tion only; or capable of operating in the reverse direction
only. We first performed FVA on a fully reversible version
of the iJR904 model without any thermodynamic constraints
(FBAr), in which all reactions (except biomass) were
allowed to be reversible. This allowed us to identify direc-
tionally constrained reactions based on stoichiometry and
the external environment.
We observed that in FBAr, the majority of reactions are
bidirectional (60%), with the remainder being constrained
in some way. On the other hand, the FBA model has a large
set of irreversible reactions, causing the number of bidirec-
tional reactions to decrease significantly, to a mere 5% of the
network. The majority of reactions in the FBA model
operate in the forward direction only, or not at all. When
we neglect a priori reaction directionality assignments andBiophysical Journal 105(2) 512–522
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FIGURE 2 Comparison of thermodynamic formulations under glucose
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516 Hamilton et al.instead allow reaction directions to be determined solely by
thermodynamic constraints (TMFA), the fraction of direc-
tionally constrained reactions becomes 85%, compared to
95% in FBA, and 40% in FBAr. This reveals that thermody-
namic constraints play a major role in eliminating some of
the network flexibility resulting from eliminating predefined
reaction directions (FBAr). We also see that, relative to FBA
(with predefined reaction directions), TMFA enabled previ-
ously forward- or reverse-only reactions to become bidirec-
tional, and previously blocked reactions to become feasible
in the reverse direction.
Just as moving from FBA to TMFA led to a decrease in
the number of constrained reactions, so too does moving
from TMFA to RTMFA. The number of constrained reac-
tions decreases from 85% in TMFA to 77% in RTMFA.
The number of bidirectional reactions increases by 50%,
as many previously forward-only reactions become feasible
in the reverse direction.Biophysical Journal 105(2) 512–522When the reaction directionalities from FVA analysis of
the TMFA model were used to further constrain fluxes in
FBAr (TMFA-LP), the predicted growth rate was 150% of
that predicted by FBA (Fig. 2 C). This increase in growth
rate indicates ATP- or other energy-generating cycles were
present in the network that are not present when thermody-
namic constraints are imposed directly. One such cycle
involves the shuttling of sodium ions back and forth across
the membrane, resulting in a proton gradient used to synthe-
size ATP (see Fig. S1 in the Supporting Material). This cycle
is infeasible under TMFA, despite each reaction operating in
a thermodynamically feasible direction. This emphasizes
the need to actively impose thermodynamic constraints
that account for thermodynamic interactions between reac-
tions (7,8,21), as opposed to methods that impose thermody-
namically feasible reaction directions without accounting
for thermodynamic coupling between reactions (17–19).
Finally, we used our FVA results from each formulation to
find a cumulative distribution function (CDF) for the flux
span, the difference between the maximum and minimum
flux through a given reaction (Fig. 2 B and see Table S9).
The CDF for FBA is the sharpest, with >90% of the reac-
tions having a span <300 mmol/gDW/h. The CDF for
TMFA is similar to that of FBA, despite the increase in
network flexibility. The CDF becomes more shallow for
RTMFA (more reactions with larger spans), as a reaction’s
span can increase if it becomes directionally unconstrained.
The CDF for TMFA-LP was the most shallow: jumps in the
CDF value at flux spans of 1000 and 2000 mmol/gDW/h
point to the existence of many thermodynamically infea-
sible closed cycles (e.g., A/ B / C / A) in which
participating reactions operate at their maximum flux. These
results highlight the important role thermodynamic interac-
tions play in shaping a feasible flux space. We also observed
that the sets of bidirectional and constrained reactions vary
slightly across media conditions, though the overall CDFs
remain qualitatively similar (data not shown).Gene deletion studies: comparison of FBA
to TMFA
Under glucose aerobic conditions, CONGA identified 22
single gene deletions for which TMFA and FBA made
different growth phenotype predictions (Table 1). In 19
cases, TMFA predicted a nonlethal phenotype and FBA pre-
dicted a lethal one, while in the remaining three cases
TMFA predicted a lethal phenotype and FBA predicted a
nonlethal one. Relative to experimental data (25), this corre-
sponded to a better prediction by TMFA in seven cases, and
a worse prediction in the remaining 15 cases. Using RTMFA
instead of TMFA introduces another two worse predictions
and one better prediction (Table 1).
For TMFA to predict growth when FBA predicts no
growth, TMFA must enable a reaction to proceed in a direc-
tion not allowed by FBA. We used a variant of SL Finder
TABLE 1 Single-gene deletions for which FBA and/or (R)TMFA predict different growth phenotypes under glucose aerobic
conditions
Gene locus Gene name Phenotype FBA TMFA TMFA (corrected) RTMFA RTMFA (corrected)
Better in TMFA b0907 serC Nonlethal Lethal Nonlethal Nonlethal Nonlethal Nonlethal
b0928 aspC Nonlethal Lethal Nonlethal Nonlethal Nonlethal Nonlethal
b2913 serA Nonlethal Lethal Nonlethal Nonlethal Nonlethal Nonlethal
b3359 argD Nonlethal Lethal Nonlethal Lethal Nonlethal Lethal
b3429 glgA Nonlethal Lethal Nonlethal Nonlethal Nonlethal Nonlethal
b3430 glgC Nonlethal Lethal Nonlethal Nonlethal Nonlethal Nonlethal
b4388 serB Nonlethal Lethal Nonlethal Nonlethal Nonlethal Nonlethal
Worse in both b0474 adk Lethal Lethal Nonlethal Lethal Nonlethal Lethal
b0720 gltA Lethal Lethal Nonlethal Lethal Nonlethal Lethal
b1207 dnaR Lethal Lethal Nonlethal Lethal Nonlethal Lethal
b2615 nadK Lethal Lethal Nonlethal Lethal Nonlethal Lethal
b2818 argA Lethal Lethal Nonlethal Lethal Nonlethal Lethal
b3607 cysE Lethal Lethal Nonlethal Lethal Nonlethal Lethal
b3608 gpsA Lethal Lethal Nonlethal Lethal Nonlethal Nonlethal
b3729 glmS Lethal Lethal Nonlethal Lethal Nonlethal Nonlethal
b3957 argE Lethal Lethal Nonlethal Lethal Nonlethal Lethal
b3958 argC Lethal Lethal Nonlethal Lethal Nonlethal Lethal
b3959 argB Lethal Lethal Nonlethal Lethal Nonlethal Lethal
b4226 ppa Lethal Lethal Nonlethal Lethal Nonlethal Lethal
b3919 tpiA Nonlethal Nonlethal Lethal Lethal Lethal Lethal
Worse in TMFA b1849 purT Nonlethal Nonlethal Lethal Lethal Nonlethal Nonlethal
b2500 purN Nonlethal Nonlethal Lethal Lethal Nonlethal Nonlethal
Better in RTMFA b0888 trxB Lethal Lethal Lethal Lethal Nonlethal Nonlethal
Worse in RTMFA b1136 icd Lethal Lethal Lethal Lethal Nonlethal Lethal
b2780 pyrG Lethal Lethal Lethal Lethal Nonlethal Lethal
Columns labeled ‘‘corrected’’ indicate RTMFA predictions after the additional phenotype-correction constraints (described in Table S10 in the Supporting
Material) are included.
Quantitative Assessment of TMFA 517(34) to identify these reactions for each knockout mutant. In
cases where TMFA makes a better prediction, we hypothe-
sized that the SL reaction is active under the mutant pheno-
type. This hypothesis can be tested by knocking out the SL
reaction from the single mutant: the resulting mutant should
be incapable of growth. Conversely, when TMFA makes a
worse prediction, the SL reaction may not operate in the pre-
dicted direction in vivo.
Of the seven deletions for which TMFA made a better
prediction than FBA, we selected two for experimental vali-
dation: DaspC and DargD. Both mutants exhibit robust
growth, and removing their SL reactions only requires
a single gene deletion. For the DaspC mutant, SL Finder
identified aspartase (encoded by aspA) as the SL reaction.
After an aspA::kan aspC double mutant proved viable
(see Fig. S2), we identified two studies reporting tyrB as
an isozyme for aspC (37,38). A tyrB::kan DaspC double
mutant proved nonviable (see Fig. S3), confirming that
tyrB and not aspA rescues the DaspC mutant. We can thus
correct the phenotype by adding tyrB as an isozyme for
aspC in the model, and by imposing a constraint that pre-
vents aspartase from operating in the reverse direction. SL
Finder also predicted that DargD was rescued by ornithine
transaminase, a reaction for which argD and astC are
reported to have activity (39,40). However, allowing orni-
thine transaminase to be reversible results in TMFA making
four worse predictions while correcting the single DargDprediction. This suggests that ornithine transaminase might
not rescue DargD. Indeed, an argD::kan DastC double
mutant proved viable (see Fig. S4), suggesting some other
reaction or that isozyme rescues the DargD mutant.
In cases where TMFAmade a worse prediction than FBA,
we developed a phenotype-correction constraint that pre-
vented the SL reaction from operating in the rescuing direc-
tion (see Table S10). In some instances, SL Finder predicted
multiple reactions that acted together to rescue the pheno-
type, or that the same reaction rescued multiple phenotypes.
For example, SL Finder predicted the reactions ornithine
transaminase and n-acetylornithine deacetylase acted
together to rescue the phenotypes of DargA, DargB, and
DargC. All told, the 12 genes for which TMFA made an
incorrect nonlethal prediction were associated with 10 SL
reactions. We were able to identify metabolite concentration
constraints for all 10 of these reactions (see Table S10),
which, when implemented in TMFA, resulted in correct
predictions for these 12 genes (Table 1). For RTMFA, there
were 19 SL reactions associated with the 14 genes for which
RTMFA made an incorrect nonlethal predictions. We were
able to identify concentration constraints for 17 of these
reactions (see Table S10), which, when implemented in
RTMFA, resulted in correct predictions for 12 of these 14
genes (Table 1). With the exception of DargD noted above,
correct TMFA and RTMFA predictions were unaffected by
these additional phenotype-correction constraints.Biophysical Journal 105(2) 512–522
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FIGURE 3 Example of reduced concentration spaces imposed by pheno-
type-correction constraints. (A) TMFA incorrectly predicts that the deletion
of gltA (citrate synthase, 2.3.3.1) is nonlethal. When gltA is deleted
(large X), TMFA predicts that citrate lyase (4.1.3.6) synthesizes citrate
(cit) by operating in reverse. (B) To correct the phenotype, citrate lyase
must be constrained to operate only in the forward direction. This requires
the ac, oaa, and cit concentrations to lie beneath the shaded surface.
518 Hamilton et al.An example of phenotype-correction constraint is illus-
trated in Fig. 3. TMFA predicts that the deletion of citrate
(cit) synthase (gltA, EC 2.3.3.1) is nonlethal, with citrate
lyase (EC 4.1.3.6) rescuing growth. In this case citrate is
synthesized from oxaloacetate (oaa) and acetate (ac),
instead of oaa and acetyl-CoA (accoa) (Fig. 3 A). We found
the phenotype-correction constraint for
DgltA to be lnðacÞ þ lnðoaaÞ  lnðcitÞ< 2:76
for TMFA, and
lnðacÞ þ lnðoaaÞ  lnðcitÞ< 7:77
for RTMFA. In Fig. 3 B, these constraints are indicated by
the shaded planes, with concentrations in the half-space
below the plane satisfying the constraint.
CONGA also identified a total of 20 double- and triple-
deletions for which TMFA predicted a nonlethal phenotype
and FBA a lethal one (see Table S11). We were able to find
experimental phenotypes for 14 of these multi-gene dele-
tions, and TMFA made a worse prediction in all cases.Biophysical Journal 105(2) 512–522Taken together with the single-gene deletion data, this
suggests that additional concentration measurements are
needed to more accurately define the metabolic flux space
and predict growth phenotypes.
We also identified three gene deletions for which TMFA
falsely predicted a lethal phenotype (Db1949, Db2500, and
Db3919) when FBA predicted a nonlethal one (Table 1). In
these cases, we hypothesized that the SL reaction active in
FBA was thermodynamically infeasible in TMFA. Indeed,
in two of the three cases, when uncertainty in free energies
was included, RTMFA made the correct prediction (the
exception being Db3919). RTMFA also picked up an
additional gene deletion (Db0888) for which TMFA and
FBA both incorrectly predicted a lethal phenotype (Table 1).
Thus, although there were cases in which thermodynamic
assignment of some reaction directions led to inaccurate
growth predictions, there were other cases where thermody-
namic constraints were needed to explain observed growth
phenotypes.
We also evaluated TMFA for aerobic growth on glycerol
and anaerobic growth on glucose (see Table S5). We found
that to enable aerobic growth in glycerol M9 medium TMFA
required the same concentration constraints as the glucose
case; however, for anaerobic growth on glucose, TMFA
required expanded concentration ranges on a slightly
different set of metabolites. We also performed CONGA
on single-gene deletions under both conditions. Under glyc-
erol aerobic conditions, we found 20 gene deletions for
which FBA and TMFA made different predictions, with
six better and 14 worse predictions (see Table S12). Under
glucose anaerobic conditions, we found 26 gene deletions
for which FBA and TMFA made different predictions. We
then performed growth phenotype screens for the 20 dele-
tion strains available in the Keio collection (see Fig. S5).
Assuming the six deletion strains that are unavailable in
the Keio collection involve essential genes (25), these
screens reveal that TMFA makes a better prediction than
FBA in eight cases and a worse prediction in 18 cases
(see Table S13).Thermodynamic variability analysis: ranges of
metabolite concentration
Thermodynamic variability analysis (TVA) was used to
study the ranges of metabolite concentrations that allow
maximal growth on glucose minimal media in the absence
of uncertainty in standard Gibbs energy of formation of
each group (Dgr G
00). Using TMFA, we identified a total
of 124 (out of 618) intracellular metabolites whose feasible
concentration range was less than the default global bounds
(0.00120 mM, see Table 2, and see Table S14 and Fig. S5),
indicating that the thermodynamic constraints impose
restrictions on metabolite concentrations.
The study of Bennett et al. (22) examined exponential
growth of E. coli, and reported measurements for 107
TABLE 2 Comparison of model-predicted and experimentally
measuredmetabolite concentration ranges for glucose aerobic
conditions at maximal growth
Predicted by TMFA
Total
Unconstrained by
thermodynamics
Constrained by
thermodynamics
Experimentally Overlap 57 16 73
Measured No overlap 11 23 34
No data 426 85 511
Total 494 124 618
‘‘Constrained’’ indicates the concentration ranges are tighter than the global
bounds (0.001–20 mM).
Quantitative Assessment of TMFA 519metabolites in the iJR904 model. Of these, predicted con-
centration ranges overlapped with their measured values
in 73 instances, and failed to overlap in 34 (Table 2,
Fig. 4, and see Fig. S6). Of these 34 metabolites (Fig. 4
A), 12 measurements did not overlap with their predicted
values because the measurements fell outside the global
bounds defined by our model. In addition, for 11 of these
12 metabolites, the concentration range predicted by
TMFA spanned the full range allowed by our global bounds,
indicating that changing the global bounds would likely
resolve these conflicts. However, doing so is unlikely to
result in tighter ranges on predicted metabolite concentra-
tions. For the remaining 22 (out of 34) conflicting metabo-
lites whose measurements did fall within the global
bounds, thermodynamic consistency (i.e., predicted concen-
trations consistent with experimental measurement) could
be achieved for all 22 metabolites by allowing for uncer-
tainty using RTMFA. However, the predicted concentration
range for all of these metabolites in RTMFA spanned the
global range, indicating that RTMFA is unable to predict
these metabolite concentrations with great precision. Of
the 73 instances of overlap between measured and TMFA
predicted values, 16 metabolites had a feasible concentra-A B
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Global Default Boundstion range that was restricted by thermodynamic constraints
(Fig. 4 B), while 57 did not (i.e., the ranges were the same as
the global bounds). These results suggest TMFA may be
more suitable as a framework for incorporating mea-
sured concentration data into constraint-based models,
rather than a tool to predict experimental concentration
measurements.
A second study, from Ishii et al. (27), examined E. coli
grown in continuous culture at 0.2 h1, and reported mea-
surements for 88 metabolites in the iJR904 model. We per-
formed TVA at this growth rate to examine the effect of
suboptimal growth on predicted metabolite concentrations.
In general, we find that fewer metabolites are predicted to
have constrained ranges during suboptimal growth (97
compared to 124, see Table S15 and Fig. S7), most likely
due to the increase in network flexibility associated with
suboptimal growth. We also compared the model predic-
tions to measurements taken from the dataset of Ishii et al.
(27) and found that more predictions agree with experi-
mental measurements (74 of 88 measurements, see Table
S16, and Fig. S8, Fig. S9, and Fig. S10). Of the 68 metabo-
lites measured in both studies, 42 predictions agreed with
experimental measurements in both studies.Examination of thermodynamic bottlenecks
Previous studies have utilized thermodynamic constraints to
identify candidate reactions for regulation (those with trans-
formed Gibbs energy of reaction (Dr G
0
) far from zero)
(21,23), and to identify thermodynamic bottlenecks in
cellular metabolism (7,23). Thermodynamic bottlenecks
were first defined as reactions that render metabolic path-
ways infeasible for a given system with known concen-
trations (41,42). The term was later used (7,23) to
describe reactions for which Dr G
0
is close to equilibrium.
Such reactions are feasible for only a narrow concentrationon (mM)
1 10 100 
FIGURE 4 Comparison of model-predicted and
experimentally observed metabolite concentrations
for maximal growth. The dataset of Bennett et al.
(22) contains metabolite concentrations for 107
metabolites in iJR904. (A) Plot of the 34 metabo-
lites for which experimental and theoretical con-
centration measurements do not overlap. (B) Plot
of the 16 metabolites for which experimental and
theoretical concentration measurements overlap,
and for which metabolite concentration ranges
are constrained by thermodynamics. (A and B)
Circles (diamonds) Mean predicted (measured)
metabolite concentration . (Horizontal bars) Full
concentration range. Metabolite abbreviations can
be found in the Supporting Material.
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520 Hamilton et al.range. Thus, the term ‘‘thermodynamic bottleneck’’ refers to
a bottleneck in the space of potential metabolite concentra-
tions. Thermodynamic models can provide quantitative
values for the feasible concentration range of metabolites
associated with a bottleneck. TVA was used to study the
ranges of reaction Gibbs energies (Dr G
0
) that allow
maximal growth on glucose minimal media in the absence
of uncertainty in Dgr G
00. Using TVA, we identified a total
of 168 reactions that must operate in a single direction
and whose free energy range includes equilibrium (see
Table S17).
One such reaction operating very close to equilibrium is
phosphoribosylaminoimidazole synthase (PRAIS), an inter-
mediate step in purine biosynthesis. We used TVA to iden-
tify the range of Dr G
0
and metabolite concentrations
consistent with cellular growth for each reaction and metab-
olite in the pathway (Fig. 5). TVA shows that the driving
force for PRAIS is a large concentration gradient between
2-formamido-n(1)-(5-phospho-D-ribosyl)acetamidine
(fpram) and 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-
carboxamide (air), and PRAIS is only feasible for a narrow
range of fpram and air concentrations. Conversely, reactions
with a large positive or negative Dr G
0
should be relatively
insensitive to metabolite concentration, and TMFA confirmsr5p
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FIGURE 5 Model-predicted concentrations and Dr G
0
ranges for
metabolites and reactions in the purine biosynthesis pathway. (Circles
and diamonds) Mean predicted concentrations (Dr G
0
). (Horizontal bars)
Full concentration (Dr G
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) range. Underlined reaction abbreviations signify
that Dr G
0
and Dr G
00 have opposite signs. Starred reaction abbreviations
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shown in the figure, and Dr G
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with the direction shown. Metabolite and reaction abbreviations can be
found in the Supporting Material
Biophysical Journal 105(2) 512–522this prediction. Reactions such as GLUPRT (Dr G
0
< 0)
remain feasible for concentration ranges spanning several
orders of magnitude. Finally, PRPP synthetase, the primary
regulatory control point for purine biosynthesis (30), also
has a free energy range far from zero.DISCUSSION
TMFA modifies flux balance analysis with thermodynamic
constraints, allowing for expanded predictive capability of
constraint-based methods. TMFA ensures that all reactions
operate in thermodynamically feasible directions, elimi-
nates thermodynamically infeasible closed cycles, and
accounts for thermodynamic coupling between reactions
in the network. In this work, we demonstrate that thermody-
namic constraints can provide a guide for predicting reac-
tion directions in the absence of prior knowledge. We also
systematically evaluated the impacts of these thermody-
namic constraints on metabolic flux distributions and
cellular growth rates, and we highlight the importance of
explicitly accounting for thermodynamic coupling between
reactions. We used TMFA to make both qualitative and
quantitative predictions, and have validated these predic-
tions against a variety of genome-scale datasets. We show
how these predictions can generate hypotheses regarding
reaction directions and thermodynamic bottlenecks. We
found many instances in which predictions of metabolite
concentrations lack precision and/or accuracy, in which
case additional types of data or constraints can be incorpo-
rated into TMFA. Identifying what additional data are most
useful is an important question that should be addressed in
the years ahead.
In this work, we found that TMFA was able to achieve
physiologically realistic predictions of growth rates and
flux distributions in the absence of uncertainty in the esti-
mated contributions of groups (Dgr G
00
k,est) to formation
energies (Df G
00), but concentration measurements for
ATP were required in the presence of uncertainty. While it
is encouraging that TMFA can reproduce wild-type growth
rates with a minimum of experimental data, we found that
additional concentration measurements may be necessary
to refine growth rate predictions for other conditions (e.g.,
for knockout mutants). We also observed that slightly
different global concentration bounds were necessary to
support growth in aerobic versus anaerobic conditions, sug-
gesting that concentration predictions are media-dependent.
TMFA can also be used to generate hypotheses regarding
reaction directions and thermodynamic bottlenecks. For
example, cofactor pairs such as ATP/ADP appear together
in numerous reactions, resulting in constraints on the con-
centration ratio of the two metabolites (7). However, we
found that constraining the ATP concentration was
necessary to achieve physiologically realistic behavior in
the presence of uncertainty in Dgr G
00
k,est estimates. Thus,
it may be that constraints on metabolite ratios serve to drive
Quantitative Assessment of TMFA 521reactions in their physiological directions. Physiological re-
action directions are often assigned based on in vitro charac-
terization of enzymes under conditions that may vary
significantly from those found in vivo. Thus, we envision
TMFA complementing other approaches (17–19,43) that
are used to calculate thermodynamically feasible reaction
directions for new genome-scale models. TMFA also prom-
ises to be a useful tool for metabolic engineering applica-
tions, by identifying thermodynamic bottlenecks in
engineered pathways (44) or by pinpointing those reactions
whose reversible operation enables new routes for chemical
synthesis (45).
We also observed that the TMFA model is limited in its
ability to predict metabolite concentrations. This may be
because the majority of reactions in the iJR904 network
are thermodynamically favorable, and thus relatively insen-
sitive to metabolite concentrations. Obtaining tighter
bounds on predicted metabolite concentrations may require
the use of a penalty function (46), a thermodynamic objec-
tive (20), or the use of kinetic constraints. Recent studies
have identified correlations between metabolite concentra-
tions and physiochemical properties (47,48), including the
KM of metabolic enzymes (22). Alternatively, incorporation
of known metabolite concentrations may enable TMFA to
predict concentrations of metabolites for which data are un-
available. In light of these results, we suggest that, without
additional constraints, TMFA is better suited for validating
phenotypes and generating hypotheses than for quantitative
prediction of metabolite concentrations.
Furthermore, our results suggest that additional types of
data and constraints will be needed to improve TMFA’s pre-
dictions of growth phenotypes and metabolite concentra-
tions due to uncertainties in Df G
00
est. A recently published
GCM provides tighter estimates for Df G
00
est (49), whereas
other approaches have successfully combined group contri-
bution estimates with experimentally measured Df G
00
values or equilibrium constants (18,21). We also observed
that the inclusion of additional constraints on cofactor con-
centrations and formation energies (ATP, NAD, NADP, etc.)
further constrains the flux space (data not shown). Thus,
experimental measurements of Df G
00 for cofactors may be
a promising way to improve the accuracy of thermodynamic
models. Finally, we note that our approach underestimates
uncertainty in Dr G
00 by neglecting the error associated
with structural groups unchanged by a reaction, an approach
that is valid only if the contributions of Dgr G
00 to Df G
00 are,
in fact, linearly additive. Additional types of data will likely
be necessary when considering the error associated with
these unchanged groups.
Associated with a need to reduce uncertainty in Df G
00
est
is a need to improve model run-time performance, as large
mixed-integer programs such as TMFA can be quite
cumbersome. A recent Master’s thesis examines a number
of thermodynamic approaches (EBA, TMFA, etc.) from a
theoretical and practical perspective, and provides insightsinto how to improve solver performance of different formu-
lations (50). We also observed that a priori thermodynamic
constraints on reaction directions (Eqs. 14–18) reduced
solution times by over an order of magnitude. Alternatively,
rather than enforcing strict thermodynamic requirements,
one could use thermodynamic and metabolomic data as a
guide, and seek a solution that maximizes the consistency
with the available data (e.g., by allowing thermodynamic
and concentration constraints to be violated, and employing
a penalty in the objective). One study suggests that metabo-
lite concentrations remain stable in response to perturba-
tions, implying a single set of metabolomics data (27)
could be used to model a variety of conditions.SUPPORTING MATERIAL
Methods, results, ten figures, and references (51–54) are available at http://
www.biophysj.org/biophysj/supplemental/S0006-3495(13)00685-1.
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